Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Hum Pathol

Retrieve available abstracts of 85 articles:
HTML format

Single Articles

    July 2021
  1. KIHARA A, Amano Y, Matsubara D, Fukushima N, et al
    Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
    Hum Pathol. 2021 Jul 13. pii: S0046-8177(21)00121.
    PubMed     Abstract available

    June 2021
  2. LAWSON BC, Yang RK, Euscher ED, Ramalingam P, et al
    TP53 Variant Allele Frequency Correlates with the Chemotherapy Response Score in Ovarian/Fallopian Tube/Peritoneal High-Grade Serous Carcinoma.
    Hum Pathol. 2021 Jun 18. pii: S0046-8177(21)00110.
    PubMed     Abstract available

    April 2021
  3. ZHANG Y, Jeyachandran D, Desouki MM
    Grossly Unremarkable Cervix in Endometrial Carcinomas: LVSI and MELF Pattern may be Associated with High Incidence of Cervical Stromal Involvement.
    Hum Pathol. 2021 Apr 29. pii: S0046-8177(21)00069.
    PubMed     Abstract available

  4. NIU N, Shen W, Zhong Y, Bast RC Jr, et al
    Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas.
    Hum Pathol. 2021 Apr 19. pii: S0046-8177(21)00054.
    PubMed     Abstract available

    March 2021
  5. ITAMI H, Fujii T, Nakai T, Takeda M, et al
    TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared to malignant mesothelioma.
    Hum Pathol. 2021 Mar 2. pii: S0046-8177(21)00032.
    PubMed     Abstract available

  6. HUVILA J, Orte K, Vainio P, Mettala T, et al
    Molecular subtype diagnosis of endometrial carcinoma: comparison of NGS panel and ProMisE classifier.
    Hum Pathol. 2021 Mar 1. pii: S0046-8177(21)00031.
    PubMed     Abstract available

    December 2020
  7. JAN VAN WEELDEN W, Reijnen C, Kusters-Vandevelde HVN, Bulten J, et al
    The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.
    Hum Pathol. 2020 Dec 15. pii: S0046-8177(20)30255.
    PubMed     Abstract available

  8. DEBELENKO L, Katsyv I, Chong AM, Peruyero L, et al
    Trophoblast Damage with Acute and Chronic Intervillositis: Disruption of Placental Barrier by SARS-CoV-2.
    Hum Pathol. 2020 Dec 12. pii: S0046-8177(20)30256.
    PubMed     Abstract available

  9. HALIMI SA, Maeda D, Ushiku-Shinozaki A, Goto A, et al
    Comprehensive immunohistochemical analysis of the gastrointestinal and Mullerian phenotypes of 139 ovarian mucinous cystadenomas.
    Hum Pathol. 2020 Dec 1. pii: S0046-8177(20)30239.
    PubMed     Abstract available

  10. MORREL B, Ewing-Graham PC, van der Avoort IAM, Pasmans SGMA, et al
    Structured analysis of histopathological characteristics of vulvar lichen sclerosus in a juvenile population.
    Hum Pathol. 2020;106:23-31.
    PubMed     Abstract available

    November 2020
  11. KITO M, Maeda D, Kudo-Asabe Y, Tamura D, et al
    Detection of MED12 Mutations in Mesenchymal Components of Uterine Adenomyomas.
    Hum Pathol. 2020 Nov 28. pii: S0046-8177(20)30241.
    PubMed     Abstract available

  12. SILVA E, Malpica A, Roma A, Ramalingam P, et al
    Ovarian Mucinous Neoplasms, Intestinal Type, in Premenopausal Patients, Develop in Abnormal Ovaries.
    Hum Pathol. 2020 Nov 20. pii: S0046-8177(20)30231.
    PubMed     Abstract available

    October 2020
  13. MODI MB, Gimotty PA, Ming ME, Jariwala N, et al
    Urethral involvement is associated with higher mortality and local recurrence in vulvar melanoma: a single institutional experience.
    Hum Pathol. 2020;104:1-8.
    PubMed     Abstract available

    September 2020
  14. MAKHDOUM S, Nardi V, Devereaux KA, Kunder CA, et al
    Inflammatory Myofibroblastic Tumors associated with the placenta, a series of 9 cases.
    Hum Pathol. 2020 Sep 21. pii: S0046-8177(20)30176.
    PubMed     Abstract available

  15. SWANSON AA, Howitt BE, Schoolmeester JK
    Criteria for risk stratification of vulvar and vaginal smooth muscle tumors: a follow-up study with application to leiomyoma variants, smooth muscle tumors of uncertain malignant potential, and leiomyosarcomas.
    Hum Pathol. 2020;103:83-94.
    PubMed     Abstract available

    July 2020
  16. GAILLOT-DURAND L, Patrier S, Aziza J, Devisme L, et al
    p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.
    Hum Pathol. 2020;101:18-30.
    PubMed     Abstract available

    June 2020
  17. ROTH LM, Cheng L
    Gonadoblastoma: origin and outcome.
    Hum Pathol. 2020;100:47-53.
    PubMed     Abstract available

    May 2020
  18. WANG L, Hu S, Xin F, Zhao H, et al
    MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
    Hum Pathol. 2020;99:36-42.
    PubMed     Abstract available

  19. OLSON NJ, Fritchie KJ, Torres-Mora J, Folpe AL, et al
    MyoD1 expression in fibroepithelial stromal polyps.
    Hum Pathol. 2020;99:75-79.
    PubMed     Abstract available

    April 2020
  20. TESSIER-CLOUTIER B, Cochrane DR, Karnezis AN, Colborne S, et al
    Proteomic Analysis of Transitional Cell Carcinoma-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma.
    Hum Pathol. 2020 Apr 29. pii: S0046-8177(20)30047.
    PubMed     Abstract available

  21. CISCATO A, Zare SY, Fadare O
    The significance of recurrence in endometrial polyps: a clinicopathologic analysis.
    Hum Pathol. 2020 Apr 22. pii: S0046-8177(20)30054.
    PubMed     Abstract available

  22. SCHOOLMEESTER JK, Minn K, Sukov WR, Halling KC, et al
    Uterine Inflammatory Myofibroblastic Tumor Involving Decidua of the Extraplacental Membranes: Report of a Case with a TIMP3-ROS1 Gene Fusion.
    Hum Pathol. 2020 Apr 2. pii: S0046-8177(20)30065.

    February 2020
  23. WIEDEMEYER K, Kobel M, Koelkebeck H, Xiao Z, et al
    High GLYPICAN-3 expression Characterizes a Biologically Distinct subset of ovarian clear cell carcinomas in Canadian patients: An Opportunity for targeted Therapy.
    Hum Pathol. 2020 Feb 1. pii: S0046-8177(20)30015.

    January 2020
  24. CHEEK EH, Fadra N, Jackson RA, Davila JI, et al
    Uterine inflammatory Myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of six cases with identification of a novel TIMP3-RET fusion.
    Hum Pathol. 2020 Jan 6. pii: S0046-8177(19)30235.
    PubMed     Abstract available

    October 2019
  25. BAI JDK, Babu S, Roa-Pena L, Hou W, et al
    Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
    Hum Pathol. 2019 Oct 23. pii: S0046-8177(19)30170.
    PubMed     Abstract available

  26. YOUNG RH, Frc, Path
    Ovarian tumors: a survey of selected advances of note during the LIFE of this journal.
    Hum Pathol. 2019 Oct 22. pii: S0046-8177(19)30167.
    PubMed     Abstract available

    August 2019
  27. NOOR M, Chen A, Gonzalez RS
    Gynecologic proliferations of the appendix.
    Hum Pathol. 2019 Aug 17. pii: S0046-8177(19)30137.
    PubMed     Abstract available

    June 2019
  28. ZANNONI GF, Santoro A, Angelico G, Spadola S, et al
    Clear cell carcinoma of the endometrium: an IMMUNOHISTOCHEMICAL and molecular analysis of 45 cases.
    Hum Pathol. 2019 Jun 30. pii: S0046-8177(19)30113.
    PubMed     Abstract available

  29. ZHOUCHUNYANG X, Cochrane DR, Tessier-Coutier B, Leung S, et al
    Expression of L1 retrotransposon open reading frame protein 1 (L1ORF1p) in gynecologic cancers.
    Hum Pathol. 2019 Jun 17. pii: S0046-8177(19)30103.
    PubMed     Abstract available

    May 2019
  30. VISSER NCM, van der Putten LJM, van Egerschot A, Van de Vijver KK, et al
    Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: an ENITEC collaboration study.
    Hum Pathol. 2019 May 2. pii: S0046-8177(19)30079.
    PubMed     Abstract available

    April 2019
  31. TOMOHIRO M, Matsumoto T, Miura R, Oguri Y, et al
    Alterations in beta-catenin, microsatellite instability, and HNF-1beta levels are independently associated with ovarian endometriosis-associated tumorigenesis.
    Hum Pathol. 2019 Apr 22. pii: S0046-8177(19)30066.
    PubMed     Abstract available

    March 2019
  32. LI N, Chen L, Liu C, Jiang Y, et al
    Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
    Hum Pathol. 2019;85:235-241.
    PubMed     Abstract available

    February 2019
  33. LU B, Teng X, Fu G, Bao L, et al
    Analysis of PD-L1 expression in trophoblastic tissues and tumors.
    Hum Pathol. 2019;84:202-212.
    PubMed     Abstract available

  34. GRIFFIN BB, Ban Y, Lu X, Wei JJ, et al
    Hydropic leiomyoma: a distinct variant of leiomyoma closely related to HMGA2 overexpression.
    Hum Pathol. 2019;84:164-172.
    PubMed     Abstract available

  35. WANG W, Song G, Lin J, Zheng X, et al
    Study of the revisited, revised, and expanded Silva pattern system for Chinese endocervical adenocarcinoma patients.
    Hum Pathol. 2019;84:35-43.
    PubMed     Abstract available

    January 2019
  36. SHEN W, Niu N, Lawson B, Qi L, et al
    GATA6: a new predictor for prognosis in ovarian Cancer.
    Hum Pathol. 2019 Jan 8. pii: S0046-8177(19)30003.
    PubMed     Abstract available

    November 2018
  37. KATO N, Sato Y, Kamataki A, Fukase M, et al
    PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
    Hum Pathol. 2018 Nov 26. pii: S0046-8177(18)30464.
    PubMed     Abstract available

  38. ISHIKAWA M, Nakayama K, Nakamura K, Ono R, et al
    High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Hum Pathol. 2018 Nov 15. pii: S0046-8177(18)30424.
    PubMed     Abstract available

  39. BPH AY, Matsumoto T, Watanabe G, Tochimoto M, et al
    Immunophenotypic profile as predictor of prognosis in advanced ovarian carcinoma.
    Hum Pathol. 2018 Nov 15. pii: S0046-8177(18)30436.
    PubMed     Abstract available

  40. BARRETA A, Sarian LO, Ferracini AC, Costa LBE, et al
    Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
    Hum Pathol. 2018 Nov 14. pii: S0046-8177(18)30427.
    PubMed     Abstract available

  41. REIJNEN C, Kusters-Vandevelde HVN, Abbink K, Zusterzeel PLM, et al
    Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma.
    Hum Pathol. 2018 Nov 11. pii: S0046-8177(18)30419.
    PubMed     Abstract available

  42. SEHOULI J, Braicu EI, Richter R, Denkert C, et al
    Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the tumor bank ovarian cancer network.
    Hum Pathol. 2018 Nov 11. pii: S0046-8177(18)30417.
    PubMed     Abstract available

  43. LIBERA L, Craparotta I, Sahnane N, Chiaravalli AM, et al
    Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
    Hum Pathol. 2018;81:235-244.
    PubMed     Abstract available

    October 2018
  44. WEGMAN SJ, Parwani AV, Zynger DL
    CK7, inhibin, and p63 in testicular germ cell tumor: superior markers of Choriocarcinoma compared to beta-hCG.
    Hum Pathol. 2018 Oct 22. pii: S0046-8177(18)30394.
    PubMed     Abstract available

  45. STRICKLAND KC, Yuan L, Quade BJ, Nucci MR, et al
    Clinicopathologic and Immunohistochemical features of uterine Adenomyomatous polyps.
    Hum Pathol. 2018 Oct 16. pii: S0046-8177(18)30388.
    PubMed     Abstract available

    August 2018
  46. PATEL V, Kipp B, Schoolmeester JK
    Corded and Hyalinized Mesonephric-like adenocarcinoma of the uterine Corpus: report of a case mimicking Endometrioid carcinoma.
    Hum Pathol. 2018 Aug 30. pii: S0046-8177(18)30334.
    PubMed     Abstract available

  47. KARPATHIOU G, Matias-Guiu X, Mobarki M, Vermesch C, et al
    Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis.
    Hum Pathol. 2018 Aug 29. pii: S0046-8177(18)30330.
    PubMed     Abstract available

  48. WANG J, Gao H, Liu G, Gu L, et al
    Tumor necrosis factor alpha-induced protein 8 expression as a predictor of prognosis and resistance in patients with advanced ovarian cancer treated with neoadjuvant chemotherapy.
    Hum Pathol. 2018 Aug 11. pii: S0046-8177(18)30301.
    PubMed     Abstract available

    June 2018
  49. PRAT J, D'Angelo E, Espinosa I
    Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.
    Hum Pathol. 2018 Jun 23. pii: S0046-8177(18)30230.
    PubMed     Abstract available

  50. LI Z, Maeda D, Kudo-Asabe Y, Tamura D, et al
    MED12 is frequently mutated in ovarian and other adnexal Leiomyomas.
    Hum Pathol. 2018 Jun 23. pii: S0046-8177(18)30224.
    PubMed     Abstract available

  51. LOPEZ LV, Bhattacharyya S, Carlsen ED, Bartlett D, et al
    NF2 and ATRX gene copy number losses on a case of ovarian ependymoma.
    Hum Pathol. 2018 Jun 23. pii: S0046-8177(18)30231.
    PubMed     Abstract available

  52. PARK JK, Otsuka N, Tomaru U, Suzuki H, et al
    Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas.
    Hum Pathol. 2018 Jun 21. pii: S0046-8177(18)30220.
    PubMed     Abstract available

    May 2018
  53. ROUGEMONT AL, Tille JC
    Role of HNF1beta in the differential diagnosis from other germ cell tumors.
    Hum Pathol. 2018 May 10. pii: S0046-8177(18)30155.
    PubMed     Abstract available

    April 2018
  54. WESTENEND PJ, Dinjens WN
    Somatic polymerase epsilon mutations as another route leading to loss of DNA MMR protein expression in endometrial carcinoma.
    Hum Pathol. 2018 Apr 7. pii: S0046-8177(18)30111.

  55. Somatic polymerase epsilo mutations as another route leading to loss of DNA MMR protein expression in endometrial carcinoma-reply.
    Hum Pathol. 2018 Apr 6. pii: S0046-8177(18)30112.

  56. GARCIA-HONDUVILLA N, Ortega MA, Asunsolo A, Alvarez-Rocha MJ, et al
    Placentas from women with pregnancy-associated venous insufficiency show villi damage with evidence of hypoxic cellular stress.
    Hum Pathol. 2018 Apr 4. pii: S0046-8177(18)30099.
    PubMed     Abstract available

    March 2018
  57. ZHANG C, Wang EY, Liu F, Sung CJ, et al
    Routine histologic features in complex atypical hyperplasia can predict the presence of endometrial carcinoma: a clinicopathologic study of 222 cases.
    Hum Pathol. 2018 Mar 17. pii: S0046-8177(18)30086.
    PubMed     Abstract available

  58. HUI P, Gysler SM, Uduman M, Togun TA, et al
    MicroRNA Signatures Discriminate Between Uterine and Ovarian Serous Carcinomas.
    Hum Pathol. 2018 Mar 5. pii: S0046-8177(18)30070.
    PubMed     Abstract available

  59. CHLOPIK A, Selim MA, Peng Y, Wu CL, et al
    Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
    Hum Pathol. 2018;73:176-183.
    PubMed     Abstract available

  60. LINTEL NJ, Luebker SA, Lele SM, Koepsell SA, et al
    MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.
    Hum Pathol. 2018;73:122-127.
    PubMed     Abstract available

  61. ROY M, Connor J, Al-Niaimi A, Rose SL, et al
    Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
    Hum Pathol. 2018;73:1-6.
    PubMed     Abstract available

    February 2018
  62. ZHANG Y, Tao L, Yin C, Wang W, et al
    Ovarian microcystic stromal tumor with undetermined potential: Case study with molecular analysis and literature review.
    Hum Pathol. 2018 Feb 16. pii: S0046-8177(18)30053.
    PubMed     Abstract available

  63. YANG Y, Wu Q, Li N, Che S, et al
    Upregulation of Tiam1 contributes to cervical cancer disease progression and indicates poor survival outcome.
    Hum Pathol. 2018 Feb 13. pii: S0046-8177(18)30046.
    PubMed     Abstract available

  64. XING D, Banet N, Sharma R, Vang R, et al
    Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
    Hum Pathol. 2018;72:160-166.
    PubMed     Abstract available

    January 2018
  65. PINTO A, Kahn RM, Rosenberg AE, Slomovitz B, et al
    Uterine Rhabdomyosarcoma in Adults.
    Hum Pathol. 2018 Jan 7. pii: S0046-8177(18)30009.
    PubMed     Abstract available

    December 2017
  66. OJALVO LS, Thompson ED, Wang TL, Meeker AK, et al
    Tumor-Associated Macrophages and the Tumor Immune Microenvironment of Primary and Recurrent Epithelial Ovarian Cancer (EOC).
    Hum Pathol. 2017 Dec 26. pii: S0046-8177(17)30478.
    PubMed     Abstract available

  67. ZHANG Q, Kanis MJ, Ubago J, Liu D, et al
    The selected biomarker analysis in five types of uterine smooth muscle tumors.
    Hum Pathol. 2017 Dec 16. pii: S0046-8177(17)30471.
    PubMed     Abstract available

    November 2017
  68. ESPINOSA I, De Leo A, D'Angelo E, Rosa-Rosa JM, et al
    Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Hum Pathol. 2017 Nov 10. pii: S0046-8177(17)30413.
    PubMed     Abstract available

    October 2017
  69. DILLON JL, Gonzalez JL, DeMars L, Bloch KJ, et al
    Universal Screening for Lynch Syndrome in Endometrial Cancers: Frequency of Germline Mutations and Identification of Patients with Lynch-Like Syndrome.
    Hum Pathol. 2017 Oct 28. pii: S0046-8177(17)30391.
    PubMed     Abstract available

  70. ESPINOSA I, D'Angelo E, Corominas M, Gonzalez A, et al
    Mixed Endometrial Carcinomas with a "Low-Grade Serous"-Like Component: a Clinicopathologic, Immunohistochemical, and Molecular Genetic Study.
    Hum Pathol. 2017 Oct 24. pii: S0046-8177(17)30385.
    PubMed     Abstract available

  71. ARTS FA, Keogh L, Smyth P, O'Toole S, et al
    miR-223 potentially targets SWI/SNF complex protein SMARCD1 in Atypical Proliferative Serous Tumor and High Grade Ovarian Serous Carcinoma.
    Hum Pathol. 2017 Oct 24. pii: S0046-8177(17)30377.
    PubMed     Abstract available

  72. VAN DER LINDEN M, Bult P, Nagtegaal ID, Massuger LFAG, et al
    Cervical metastases originating from a primary rectal adenocarcinoma due to a pagetoid spread.
    Hum Pathol. 2017;68:184-188.
    PubMed     Abstract available

    September 2017
  73. CRAMER SF, Heller DS
    Postablation neuroma of the myometrium-a report of 5 cases.
    Hum Pathol. 2017;67:211-216.
    PubMed     Abstract available

  74. CHEN AL, Goldfarb IT, Scourtas AO, Roberts DJ, et al
    The histologic evolution of revealed, acute abruptions.
    Hum Pathol. 2017;67:187-197.
    PubMed     Abstract available

  75. GIANNICO GA, Gown AM, Epstein JI, Revetta F, et al
    Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Hum Pathol. 2017;67:152-159.
    PubMed     Abstract available

    August 2017
  76. LIU Y, Alqatari M, Sultan K, Ye F, et al
    Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Hum Pathol. 2017;66:144-151.
    PubMed     Abstract available

    July 2017
  77. SCHOOLMEESTER JK, Moyer AM, Goodenberger ML, Keeney GL, et al
    Pathologic Findings in Breast, Fallopian Tube and Ovary Specimens in non-BRCA Hereditary Breast and/or Ovarian Cancer Syndromes: A Study of 18 Patients with Deleterious Germline Mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH or CHEK2.
    Hum Pathol. 2017 Jul 11. pii: S0046-8177(17)30240.
    PubMed     Abstract available

  78. CAO L, Sun PL, Yao M, Chen S, et al
    Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
    Hum Pathol. 2017;65:194-200.
    PubMed     Abstract available

  79. ZHANG Y, Xia P, Zhang W, Yan M, et al
    Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation.
    Hum Pathol. 2017;65:113-122.
    PubMed     Abstract available

    March 2017
  80. PETA E, Cappellesso R, Masi G, Sinigaglia A, et al
    Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
    Hum Pathol. 2017;61:33-40.
    PubMed     Abstract available

    February 2017
  81. BRONER EC, Trope CG, Reich R, Davidson B, et al
    TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma.
    Hum Pathol. 2017;60:180-187.
    PubMed     Abstract available

    January 2017
  82. VELEZ-PEREZ A, Wang XI, Li M, Zhang S, et al
    SIRT1 overexpression in cervical squamous intraepithelial lesions and invasive squamous cell carcinoma.
    Hum Pathol. 2017;59:102-107.
    PubMed     Abstract available

  83. KOENEMAN MM, van Lint FH, van Kuijk SM, Smits LJ, et al
    A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters.
    Hum Pathol. 2017;59:62-69.
    PubMed     Abstract available

    September 2016
  84. SCHOLZ B, Beckert M, Mordstein V, Hohmann N, et al
    Seromucinous borderline tumor of the testis-a case report.
    Hum Pathol. 2016 Sep 2. pii: S0046-8177(16)30206.
    PubMed     Abstract available

    March 2016
  85. MANDATO VD, Aguzzoli L, Costagliola L, Abrate M, et al
    Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation.
    Hum Pathol. 2016 Mar 4. pii: S0046-8177(16)00073.

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.